New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults: a multicenter retrospective cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults : a multicenter retrospective cohort study. / Fernando, Shannon M; Mathew, Rebecca; Hibbert, Benjamin; Rochwerg, Bram; Munshi, Laveena; Walkey, Allan J; Møller, Morten Hylander; Simard, Trevor; Di Santo, Pietro; Ramirez, F Daniel; Tanuseputro, Peter; Kyeremanteng, Kwadwo.
In: Critical Care, Vol. 24, 15, 2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults
T2 - a multicenter retrospective cohort study
AU - Fernando, Shannon M
AU - Mathew, Rebecca
AU - Hibbert, Benjamin
AU - Rochwerg, Bram
AU - Munshi, Laveena
AU - Walkey, Allan J
AU - Møller, Morten Hylander
AU - Simard, Trevor
AU - Di Santo, Pietro
AU - Ramirez, F Daniel
AU - Tanuseputro, Peter
AU - Kyeremanteng, Kwadwo
PY - 2020
Y1 - 2020
N2 - BACKGROUND: New-onset atrial fibrillation (NOAF) is commonly encountered in critically ill adults. Evidence evaluating the association between NOAF and patient-important outcomes in this population is conflicting. Furthermore, little is known regarding the association between NOAF and resource use or hospital costs.METHODS: Retrospective analysis (2011-2016) of a prospectively collected registry from two Canadian hospitals of consecutive ICU patients aged ≥ 18 years. We excluded patients with a known history of AF prior to hospital admission. Any occurrence of atrial fibrillation (AF) was prospectively recorded by bedside nurses. The primary outcome was hospital mortality, and we used multivariable logistic regression to adjust for confounders. We used a generalized linear model to evaluate contributors to total cost.RESULTS: We included 15,014 patients, and 1541 (10.3%) had NOAF during their ICU admission. While NOAF was not associated with increased odds of hospital death among the entire cohort (adjusted odds ratio [aOR] 1.02 [95% confidence interval [CI] 0.97-1.08]), an interaction was noted between NOAF and sepsis, and the presence of both was associated with higher odds of hospital mortality (aOR 1.28 [95% CI 1.09-1.36]) than either alone. Patients with NOAF had higher total costs (cost ratio [CR] 1.09 [95% CI 1.02-1.20]). Among patients with NOAF, treatment with a rhythm-control strategy was associated with higher costs (CR 1.24 [95% CI 1.07-1.40]).CONCLUSIONS: While NOAF was not associated with death or requiring discharge to long-term care among critically ill patients, it was associated with increased length of stay in ICU and increased total costs.
AB - BACKGROUND: New-onset atrial fibrillation (NOAF) is commonly encountered in critically ill adults. Evidence evaluating the association between NOAF and patient-important outcomes in this population is conflicting. Furthermore, little is known regarding the association between NOAF and resource use or hospital costs.METHODS: Retrospective analysis (2011-2016) of a prospectively collected registry from two Canadian hospitals of consecutive ICU patients aged ≥ 18 years. We excluded patients with a known history of AF prior to hospital admission. Any occurrence of atrial fibrillation (AF) was prospectively recorded by bedside nurses. The primary outcome was hospital mortality, and we used multivariable logistic regression to adjust for confounders. We used a generalized linear model to evaluate contributors to total cost.RESULTS: We included 15,014 patients, and 1541 (10.3%) had NOAF during their ICU admission. While NOAF was not associated with increased odds of hospital death among the entire cohort (adjusted odds ratio [aOR] 1.02 [95% confidence interval [CI] 0.97-1.08]), an interaction was noted between NOAF and sepsis, and the presence of both was associated with higher odds of hospital mortality (aOR 1.28 [95% CI 1.09-1.36]) than either alone. Patients with NOAF had higher total costs (cost ratio [CR] 1.09 [95% CI 1.02-1.20]). Among patients with NOAF, treatment with a rhythm-control strategy was associated with higher costs (CR 1.24 [95% CI 1.07-1.40]).CONCLUSIONS: While NOAF was not associated with death or requiring discharge to long-term care among critically ill patients, it was associated with increased length of stay in ICU and increased total costs.
KW - Aged
KW - Aged, 80 and over
KW - Atrial Fibrillation/complications
KW - Cohort Studies
KW - Critical Illness/epidemiology
KW - Female
KW - Humans
KW - Intensive Care Units/organization & administration
KW - Logistic Models
KW - Male
KW - Middle Aged
KW - Odds Ratio
KW - Ontario
KW - Outcome Assessment, Health Care/statistics & numerical data
KW - Registries/statistics & numerical data
KW - Retrospective Studies
KW - Risk Factors
KW - Statistics, Nonparametric
KW - Time Factors
U2 - 10.1186/s13054-020-2730-0
DO - 10.1186/s13054-020-2730-0
M3 - Journal article
C2 - 31931845
VL - 24
JO - Critical Care
JF - Critical Care
SN - 1364-8535
M1 - 15
ER -
ID: 261628520